Literature DB >> 14350204

Implications of the phenomenon of open cavity healing for the chemotherapy of pulmonary tuberculosis.

W F RUSSEL, S H DRESSLER, G MIDDLEBROOK, J DENST.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS, PULMONARY/therapy

Mesh：

Year:  1955        PMID： 14350204

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  7 in total

1.  Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients.

Authors:  A D HEATON; W F RUSSELL; J DENST; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

Authors:  S VELU; R H ANDREWS; S DEVADATTA; W FOX; S RADHAKRISHNA; C V RAMAKRISHNAN; J B SELKON; P R SOMASUNDARAM; T V SUBBAIAH
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

3.  Postural dependency treatment in cavernous pulmonary tuberculosis.

Authors:  E O HENSCHEL
Journal:  Can Med Assoc J       Date:  1957-09-01       Impact factor: 8.262

4.  [Significance of rest caverns after sputum conversion].

Authors:  H Eule; E G Ewert
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1966

5.  DosS responds to a reduced electron transport system to induce the Mycobacterium tuberculosis DosR regulon.

Authors:  Ryan W Honaker; Rakesh K Dhiman; Prabagaran Narayanasamy; Dean C Crick; Martin I Voskuil
Journal:  J Bacteriol       Date:  2010-10-15       Impact factor: 3.490

6.  Individual Mycobacterium tuberculosis universal stress protein homologues are dispensable in vitro.

Authors:  S M Hingley-Wilson; K E A Lougheed; K Ferguson; S Leiva; H D Williams
Journal:  Tuberculosis (Edinb)       Date:  2010-06-11       Impact factor: 3.131

7.  Unique roles of DosT and DosS in DosR regulon induction and Mycobacterium tuberculosis dormancy.

Authors:  Ryan W Honaker; Rachel L Leistikow; Iona L Bartek; Martin I Voskuil
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.